1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer (IARC): Lyon, France, 2008, 439.
2. Perrone S, D'Elia GM, Annechini G, Pulsoni A . Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective Therapy. Mediterr J Hematol Infect Dis 2016; 8: e2016006.
3. Arcaini L, Burcheri S, Rossi A, Paulli M, Bruno R, Passamonti F et al. Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. Ann Oncol 2007; 18: 346–350.
4. ECDC. Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies. Technical Report. 2010 European Centre for Disease Prevention and Control: Stockholm, Sweden.
5. Gheorghe L, Csiki IE, Iacob S, Gheorghe C, Smira G, Regep L . The prevalence and risk factors of hepatitis C virus infection in adult population in Romania: a nationwide survey 2006 - 2008. J Gastrointestin Liver Dis 2010; 19: 373–379.